Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy

Urothelial bladder cancer (UBC) is heterogeneous at the clinical, pathological, and genetic levels. Tumor invasiveness (T) and grade (G) are the main factors associated with outcome and determine patient management (1). A discovery exome sequencing screen (n=17), followed by a prevalence screen (n=6...

Descripción completa

Detalles Bibliográficos
Autores principales: Balbás-Martínez, Cristina, Sagrera, Ana, Carrillo-de-Santa-Pau, Enrique, Earl, Julie, Márquez, Mirari, Vazquez, Miguel, Lapi, Eleonora, Castro-Giner, Francesc, Beltran, Sergi, Bayés, Mònica, Carrato, Alfredo, Cigudosa, Juan C., Domínguez, Orlando, Gut, Marta, Herranz, Jesús, Juanpere, Núria, Kogevinas, Manolis, Langa, Xavier, López-Knowles, Elena, Lorente, José A., Lloreta, Josep, Pisano, David G., Richart, Laia, Rico, Daniel, Salgado, Rocío N., Tardón, Adonina, Chanock, Stephen, Heath, Simon, Valencia, Alfonso, Losada, Ana, Gut, Ivo, Malats, Núria, Real, Francisco X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840052/
https://www.ncbi.nlm.nih.gov/pubmed/24121791
http://dx.doi.org/10.1038/ng.2799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840052/
https://www.ncbi.nlm.nih.gov/pubmed/24121791
http://dx.doi.org/10.1038/ng.2799

Ejemplares similares